Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
12/26/2012 | CN102836288A Magnetic Chinese medicine dressing for treating scars and preparation method of same |
12/26/2012 | CN102836287A Chinese medicinal ointment for treating scar and preparation method thereof |
12/26/2012 | CN102836284A Locust medicinal liquor |
12/26/2012 | CN102836258A Compound preparation used for treating scabies |
12/26/2012 | CN102836255A Herbal medicine bath preparation |
12/26/2012 | CN102836253A Medicine for treating burns and scalds and preparation method thereof |
12/26/2012 | CN102836252A Pedicure drugs |
12/26/2012 | CN102836242A External medicament for treating scalds and burns |
12/26/2012 | CN102836235A Chinese medicinal composition for treating scalds and burns and preparation method thereof |
12/26/2012 | CN102836224A Traditional Chinese medicine preparation for treating pressure sores |
12/26/2012 | CN102836210A Vinegar-frying preparation method of traditional Chinese medicine salvia miltiorrhiza |
12/26/2012 | CN102836206A Chinese and western medicine compound emulsifiable paste for diminishing melanins and brightening and preparation method thereof |
12/26/2012 | CN102836192A Purple lucid ganoderma traditional Chinese drug composition and preparation method thereof |
12/26/2012 | CN102836187A Method for processing radix dipsaci |
12/26/2012 | CN102836173A Red upborne elixir medicament for treating sore purulence and preparation method thereof |
12/26/2012 | CN102836115A Mung bean and bamboo salt facial mask and preparation method of facial mask |
12/26/2012 | CN102836096A Iodine-containing sterilization type foot bathing liquid |
12/26/2012 | CN102836095A Iodine-containing sterilization type skin care oil |
12/26/2012 | CN102274377B Chinese medicinal composition for treating superficial mycosis infection and medicinal composition thereof |
12/26/2012 | CN102274320B Externally-applied heat-reducing medicinal liquor and use thereof |
12/26/2012 | CN102266435B Traditional Chinese medicine for treating psoriasis |
12/26/2012 | CN102258746B Ointment for treating surface of burns and scalds |
12/26/2012 | CN102258687B Hair-darkening health-care medicinal wine and preparation method thereof |
12/26/2012 | CN102247500B External use medicinal ointment for treating anorectal diseases and preparation method thereof |
12/26/2012 | CN102218132B Medicinal composition for treating nasal bleeding |
12/26/2012 | CN102178935B Preparation for resisting radiation, enhancing body immunity and preventing and treating tumors |
12/26/2012 | CN102049034B Hoof nail polypeptide preparation for promoting tissue repair and preparation method thereof |
12/26/2012 | CN102038675B Application of ampelopsin for preparing medicaments for treating acne abscess, ulcer fester and piles |
12/26/2012 | CN102038638B 盐酸克林霉素注射液及其制备方法 Clindamycin Hydrochloride Injection and its preparation method |
12/26/2012 | CN101856419B Chinese medicament Quzhenling liniment for treating infant eczema |
12/26/2012 | CN101524377B Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
12/26/2012 | CN101313926B Transcription regulating and controlling article composition |
12/26/2012 | CN101139392B KDR peptides and vaccines containing the same |
12/26/2012 | CN100998864B Cyclosporin A semisolid skeleton capsule |
12/25/2012 | US8338431 Phosphodiesterase inhibitors |
12/25/2012 | US8337834 Methods of making enhanced, autologous fat grafts |
12/25/2012 | US8337829 Conditioned medium and proliferated cell lines produced therefrom |
12/20/2012 | WO2012174055A1 Wound healing using complement inhibitors |
12/20/2012 | WO2012173383A2 Skin composition for external use containing cryptotanshinone as active ingredient |
12/20/2012 | WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same |
12/20/2012 | WO2012172318A1 Formulations containing tropolonoids, copper salt and a solvent system |
12/20/2012 | WO2012172218A2 Plant extract complex for skin protection |
12/20/2012 | WO2012172057A2 Use of a compound comprising at least one nucleophilic function for capturing carbonyl compounds resulting from the reaction between one or more compounds constituting sebum and ozone |
12/20/2012 | WO2012171125A1 N,n,n-trialkylpolymers, methods of their preparation and uses thereof |
12/20/2012 | WO2012119780A3 Novel lipids and novel phospholipids structures |
12/20/2012 | WO2012108676A3 Novel compound having skin-whitening, anti-oxidizing and ppar activities and medical use therefor |
12/20/2012 | WO2011117378A3 Compositions comprising brimonidine for the treatment of erythema |
12/20/2012 | WO2007113356A3 Synthetic peptides used for treating the skin and use thereof in cosmetic or dermopharmaceutical compositions |
12/20/2012 | US20120323164 Photodynamic therapy with phthalocyanines and radical sources |
12/20/2012 | US20120322887 Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation |
12/20/2012 | US20120322882 Compositions And Methods For Stimulating Hair Growth |
12/20/2012 | US20120322877 (bis)urea and (bis)thiorea compounds as eipgenic modulators of lysine-specific demethylase 1 and methods of treating disorders |
12/20/2012 | US20120322837 Amide compound and medicinal use thereof |
12/20/2012 | US20120322829 Use of a dipyridyl compound for treating rosacea |
12/20/2012 | US20120322825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
12/20/2012 | US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist |
12/20/2012 | US20120322801 Heterocyclic amides as rock inhibitors |
12/20/2012 | US20120322799 Deuterated compounds useful for treating neurodegenerative diseases |
12/20/2012 | US20120322798 Modulators of ATP-Binding Cassette Transporters |
12/20/2012 | US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists |
12/20/2012 | US20120322782 Veterinary compositions |
12/20/2012 | US20120322778 Pharmaceutical compositions |
12/20/2012 | US20120322776 Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants |
12/20/2012 | US20120322751 use of rhamnolipids as a drug of choice in the case of nuclear disasters in the treatment of the combination radiation injuries and illnesses in humans and animals |
12/20/2012 | US20120322731 Novel cytokine containing compositions |
12/20/2012 | US20120322729 High activity growth factor mutants |
12/20/2012 | US20120322722 Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use |
12/20/2012 | US20120321708 Sustained-release formulations of topiramate |
12/20/2012 | US20120321692 Methods and Dressings for Sealing Internal Injuries |
12/20/2012 | US20120321685 Compositions containing oils having a specific gravity higher than the specific gravity of water |
12/20/2012 | US20120321683 Liposome-Encapsulated Bicelles and Use Thereof in Diluted Systems |
12/20/2012 | US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE |
12/20/2012 | US20120321632 Neutralizing prolactin receptor antibodies and their therapeutic use |
12/20/2012 | US20120321629 Stem cell factor inhibitor |
12/20/2012 | US20120321614 Antibodies to c-met |
12/20/2012 | US20120321613 Molecular targets for healing or treating wounds |
12/20/2012 | US20120321603 Composition and method for stabilization and delivery of therapeutic molecules |
12/20/2012 | US20120321591 Anti-angiogenic compounds |
12/20/2012 | US20120321579 Surfactant compositions |
12/20/2012 | US20120321575 Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis |
12/20/2012 | US20120321573 Compositions and methods of prophylaxis for contact dermatitis |
12/20/2012 | US20120321571 Paraben compositions |
12/20/2012 | US20120321566 Inhibition of biofilm formation by 1,2,3,4,6-penta-o-galloyl-d-glucopyranose |
12/20/2012 | US20120318262 Pyrvinium Wound Treatment Methods and Devices |
12/19/2012 | EP2535353A1 Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same |
12/19/2012 | EP2535059A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
12/19/2012 | EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
12/19/2012 | EP2533801A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention |
12/19/2012 | EP2533776A1 A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation |
12/19/2012 | EP2533754A2 Compositions and methods for reducing appearance of under-eye dark circles |
12/19/2012 | CN202605351U Low-acid gingko treatment device |
12/19/2012 | CN202605349U Temple ginkgo leaf patch |
12/19/2012 | CN102834383A Cysteine protease inhibitors |
12/19/2012 | CN102834101A Biodegradable material containing silicon, for pro-angiogenetic therapy |
12/19/2012 | CN102827899A Gracilaria lemaneiformis agar oligosaccharide and preparation method and application thereof |
12/19/2012 | CN102827253A Micro-molecular polypeptide inhibiting inflammatory response, and application thereof |
12/19/2012 | CN102827228A Silicon phthalocyanine modified by cytidine derivative and preparation method and application thereof |
12/19/2012 | CN102827227A Silicon phthalocyanine modified by adenosine derivative and preparation method and application thereof |
12/19/2012 | CN102827226A Silicon phthalocyanine modified by uridine derivatives and preparation method and application of silicon phthalocyanine |
12/19/2012 | CN102827049A (Thiosemicarbazideformyl) phenoxyacetic acid derivative and application thereof |